Genomic analysis in oral squamous cell carcinoma detected by restriction landmark genomic scanning

通过限制性标志基因组扫描检测口腔鳞状细胞癌的基因组分析

基本信息

  • 批准号:
    10671899
  • 负责人:
  • 金额:
    $ 1.6万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    1998
  • 资助国家:
    日本
  • 起止时间:
    1998 至 1999
  • 项目状态:
    已结题

项目摘要

Although a considerable amount of cytogenetic and molecular data on oral squamous cell carcinoma (OSCC) has accumulated over the last few years, the picture is still incomplete in terms of how genetic alterations are involved in tumor initiations and progression. We, therefore, examined genetic abnormalities in OSCC using restriction landmark genomic scanning (RLGS), a method of two-dimensional gel analysis allowing detection of amplifications and other aberrations in genomic DNA. At first, DNA extracted from each of four oral carcinoma cell lines (Ca9-22, HO-1-u-1, HSC-2, KB) was examined. Isolated cell line and normal oral epithial DNAs were sequentially cleaved with specific restriction enzymes, radiolabelled and separated in two-dimensional gel electrophoresis. Thirteen distinct fragments were commonly amplified in the oral cancer cell lines, six of which were evident in all samples. Secondly, eleven cases of OSCC were also examined in the same manner. Five fragment/spots were found and amplified in at least 64% (7/11) (chromosomenos.4,9-12 or 22) of carcinomas, with one of these sports amplified in 100% (chromosome no.4) of tumor samples. In addition, six other spots were frequently reduced in at least 55% (chromosome nos.15 or 9-12) of tumor tissues. Then, the question of whether the DNA alterations involve not only genetic but also epigenetic change was examined using cell lines-Ca9-22, HO-1-u1, HSC-2 and KB-and treatment with a demethylating agent, 5-aza-2'-deoxycytidine (5-AzaCDR). Intensities of two of the reduced sports were amplified in the cell lines by the 5-AzaCDR treatment, showing that they were due to altered DNA methylation. The current studies provide clear evidence that epigenetic changes, like the methylation are related to oral carcinogenesis.
虽然在过去的几年里,口腔鳞状细胞癌(OSCC)的细胞遗传学和分子生物学数据已经积累了相当多的,图片仍然是不完整的遗传变异是如何参与肿瘤的发生和发展。因此,我们使用限制性标志基因组扫描(RLGS),一种二维凝胶分析方法,可以检测基因组DNA中的扩增和其他畸变,检查口腔鳞癌的遗传异常。首先,检测从4种口腔癌细胞系(Ca 9 -22、HO-1-u-1、HSC-2、KB)中提取的DNA。分离的细胞系和正常口腔上皮DNA依次用特异性限制性内切酶切割,放射性标记并在二维凝胶电泳中分离。口腔癌细胞系中通常扩增出13个不同的片段,其中6个片段在所有样本中都很明显。其次,还以同样的方式检查了11例OSCC。在至少64%(7/11)(4号、9 -12号或22号染色体)的癌中发现并扩增了5个片段/点,其中一个片段/点在100%(4号染色体)的肿瘤样品中扩增。此外,在至少55%的肿瘤组织(15号或9-12号染色体)中,其他6个斑点经常减少。然后,使用细胞系Ca 9 -22、HO-1-u1、HSC-2和KB并用去甲基化剂5-氮杂-2 '-脱氧胞苷(5-AzaCDR)处理,检查DNA改变是否不仅涉及遗传变化,而且涉及表观遗传变化。通过5-AzaCDR处理,在细胞系中扩增了两种减少的运动的强度,表明它们是由于改变的DNA甲基化。目前的研究提供了明确的证据表明,表观遗传变化,如甲基化与口腔癌的发生有关。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SUGIMURA Masahito其他文献

SUGIMURA Masahito的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SUGIMURA Masahito', 18)}}的其他基金

Analyzes of p16/CDKN2.p53 and ras gene mutations with cell-proliferative activities in oral squamous cell carcinomas and the premalignant lesions
口腔鳞癌及癌前病变中p16/CDKN2.p53和ras基因突变与细胞增殖活性的分析
  • 批准号:
    06672011
  • 财政年份:
    1994
  • 资助金额:
    $ 1.6万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

Analysis of the antioxidant function of xCT in lymphatic endothelial cells and its significance in oral squamous cell carcinoma.
淋巴管内皮细胞xCT抗氧化功能分析及其在口腔鳞癌中的意义
  • 批准号:
    23K16139
  • 财政年份:
    2023
  • 资助金额:
    $ 1.6万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Search for therapeutic target molecules based on temporal hierarchical analysis of Oral squamous cell carcinoma and functional RNA molecules
基于口腔鳞状细胞癌和功能RNA分子的时间层次分析寻找治疗靶分子
  • 批准号:
    23K16142
  • 财政年份:
    2023
  • 资助金额:
    $ 1.6万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Investigating a new vulnerability in oral squamous cell carcinoma
研究口腔鳞状细胞癌的新脆弱性
  • 批准号:
    10714352
  • 财政年份:
    2023
  • 资助金额:
    $ 1.6万
  • 项目类别:
"Role of Amplified Protein Kinases in Head and Neck Squamous Cell Carcinoma Progression and Therapy Resistance."
“扩增的蛋白激酶在头颈鳞状细胞癌进展和治疗耐药中的作用。”
  • 批准号:
    10725901
  • 财政年份:
    2023
  • 资助金额:
    $ 1.6万
  • 项目类别:
HMGB1 in EB-Associated Squamous Cell Carcinoma
EB 相关鳞状细胞癌中的 HMGB1
  • 批准号:
    10676346
  • 财政年份:
    2023
  • 资助金额:
    $ 1.6万
  • 项目类别:
Development of miR-27a* for the Treatment of Head and Neck Squamous Cell Carcinoma
开发 miR-27a* 用于治疗头颈鳞状细胞癌
  • 批准号:
    10752726
  • 财政年份:
    2023
  • 资助金额:
    $ 1.6万
  • 项目类别:
Functional heterogeneity of cancer-associated fibroblasts in head and neck squamous cell carcinoma and development of therapeutic strategies
头颈鳞状细胞癌中癌症相关成纤维细胞的功能异质性及治疗策略的开发
  • 批准号:
    23K08956
  • 财政年份:
    2023
  • 资助金额:
    $ 1.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of treatment to lymph node metastasis by Epitranscriptome regulation in Esophageal squamous cell carcinoma
表观转录组调控食管鳞癌淋巴结转移治疗进展
  • 批准号:
    23K15512
  • 财政年份:
    2023
  • 资助金额:
    $ 1.6万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Mechanisms of Pip4k2c and Pip5k1b dependencies in Ras driven squamous cell carcinoma
Ras 驱动的鳞状细胞癌中 Pip4k2c 和 Pip5k1b 依赖性的机制
  • 批准号:
    10667117
  • 财政年份:
    2023
  • 资助金额:
    $ 1.6万
  • 项目类别:
3D Culture Models of Partial-EMT and Its Regulation in Oral Cavity Squamous Cell Carcinoma
口腔鳞状细胞癌部分EMT的3D培养模型及其调控
  • 批准号:
    10723327
  • 财政年份:
    2023
  • 资助金额:
    $ 1.6万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了